Drug intelligence / Profile preview

HOXD10 siRNA

Development stage
Unknown
Lead developer
Thermo Fisher Scientific
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

HOXD10 siRNA is a small interfering RNA designed to silence the expression of the Homeobox D10 (HOXD10) gene. HOXD10 is a transcription factor that plays a critical role in embryonic development and cellular differentiation. In the context of oncology, HOXD10 is frequently characterized as a tumor suppressor, particularly in breast cancer, where its downregulation (often mediated by microRNAs like miR-10b) is associated with increased cell migration, invasion, and metastasis. Consequently, HOXD10 siRNA is primarily utilized as a research tool in laboratory settings to investigate the functional consequences of HOXD10 loss-of-function, allowing researchers to delineate its regulatory pathways and its impact on the epithelial-mesenchymal transition (EMT). While siRNA technology is a recognized therapeutic modality, HOXD10 siRNA has not yet transitioned into clinical development as a therapeutic agent.

Other names
siRNA targeting HOXD10Homeobox D10 siRNA
02

Targets

HOX (HOX transcription factor family)AGO2 (Argonaute RISC catalytic component 2)

Beyond the preview

Go deeper on HOXD10 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HOXD10 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call